Last reviewed · How we verify
NCT03928496
Abobotulinumtoxina Efficacy in Post-Traumatic Headache
Phase 4 trial testing AbobotulinumtoxinA in Post-Traumatic Headache in 40 participants. Completed in 2 February 2017.
2 February 2017
Quick facts
| Lead sponsor | VA Greater Los Angeles Healthcare System |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 August 2013 |
| Primary completion | 2 February 2017 |
| Estimated completion | 2 February 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- AbobotulinumtoxinA — full drug profile →
- Normal saline
Conditions studied
- Post-Traumatic Headache — all drugs for Post-Traumatic Headache →
Sponsor
VA Greater Los Angeles Healthcare System — full company profile →
Who can join
Adults 18 to 65, any sex, with Post-Traumatic Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the efficacy of abobotulinumtoxina on Veterans with post-traumatic headache
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine.
Lambru G, Benemei S, Andreou AP, Luciani M, et al · · 2021 · cited 16× · PMID 33247827 · DOI 10.1007/s40122-020-00220-1
Verify or expand the search:
- PubMed search for NCT03928496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AbobotulinumtoxinA
Trials testing the same drug.
- NCT05466539 — Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A · Phase 4 · completed
- NCT05089357 — Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin · completed
- NCT04886167 — Dysport Dose-Ranging Treatment of Platysmal Bands · Phase 1, PHASE2 · unknown
- NCT03935295 — Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis · Phase 4 · recruiting
- NCT03960957 — Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines · Phase 3 · completed
Other recruiting trials for Post-Traumatic Headache
Currently open trials in the same condition.
- NCT06069791 — Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1 · Phase 1 · recruiting
- NCT05857761 — GAIN Symptoms: Post-traumatic Headache · NA · active not recruiting
- NCT06015451 — Exercise in Postconcussion Symptoms and Posttraumatic Headache · NA · recruiting
Other VA Greater Los Angeles Healthcare System trials
Trials by the same sponsor.
- NCT07031245 — Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout · NA · recruiting
- NCT06932289 — Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions · NA · not yet recruiting
- NCT06706921 — 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer · Phase 4 · recruiting
- NCT06039865 — Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial · NA · completed
- NCT05820724 — PSMA PET Scan and mpMRI for Prostate Cancer Detection · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03928496 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VA Greater Los Angeles Healthcare System
- Last refreshed: 26 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03928496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing